Cargando…

Norepinephrine: the next therapeutics frontier for Parkinson's disease

Tissue concentrations of norepinephrine (NE) are markedly decreased in various regions of the Parkinson's disease (PD) brain. As in the substantia nigra pars compacta, neuronal dropout and Lewy bodies are prominent changes affecting the locus coeruleus, which is the source of ascending NErgic p...

Descripción completa

Detalles Bibliográficos
Autor principal:	LeWitt, Peter A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506997/ https://www.ncbi.nlm.nih.gov/pubmed/23211006 http://dx.doi.org/10.1186/2047-9158-1-4

Ejemplares similares

Drugs to the Rescue: Comparison of On-Demand Therapies for OFF Symptoms in Parkinson’s Disease
por: Martinez-Nunez, Alfonso E., et al.
Publicado: (2023)

Parkinson Disease and Orthostatic Hypotension in the Elderly: Recognition and Management of Risk Factors for Falls
por: LeWitt, Peter A, et al.
Publicado: (2019)

Application of Neuromelanin MR Imaging in Parkinson Disease
por: He, Naying, et al.
Publicado: (2022)

Polymer therapeutics in surgery: the next frontier
por: Azzopardi, Ernest A., et al.
Publicado: (2016)

What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson’s Disease Patients and Healthy Subjects with Parkinson’s-Associated LRRK2 Mutations?
por: Loeffler, David A., et al.
Publicado: (2019)

Retinal Diseases: The Next Frontier in Pharmacodelivery
por: Ben-Arzi, Assaf, et al.
Publicado: (2022)

Locus coeruleus-norepinephrine: basic functions and insights into Parkinson’s disease
por: Bari, Bilal Abdul, et al.
Publicado: (2019)

Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER
por: LeWitt, Peter A., et al.
Publicado: (2012)

Pulmonary Safety and Tolerability of Inhaled Levodopa (CVT-301) Administered to Patients with Parkinson's Disease
por: LeWitt, Peter A., et al.
Publicado: (2018)

The Next Frontiers
por: Porcino, Antony
Publicado: (2013)

The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease
por: Vazey, Elena M., et al.
Publicado: (2012)

Microbiome: The Next Frontier in Psychedelic Renaissance
por: Kargbo, Robert B.
Publicado: (2023)

Systems Biology: The Next Frontier for Bioinformatics
por: Likić, Vladimir A., et al.
Publicado: (2010)

Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's disease
por: Camp, Dianne M, et al.
Publicado: (2009)

Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson’s Disease-Associated LRRK2 Gene Mutations
por: Loeffler, David A., et al.
Publicado: (2017)

The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease: A Post Hoc Analysis
por: LeWitt, Peter A., et al.
Publicado: (2016)

Effect of Concomitant Medications on the Safety and Efficacy of Extended-Release Carbidopa-Levodopa (IPX066) in Patients With Advanced Parkinson Disease: A Post Hoc Analysis
por: LeWitt, Peter A., et al.
Publicado: (2018)

Together to the next frontier
por: Lockyer, Nigel
Publicado: (2013)

Coronary Microcirculation: The Next Frontier in the Management of STEMI
por: Milasinovic, Dejan, et al.
Publicado: (2023)

Gut Microbiota: The Next-Gen Frontier in Preventive and Therapeutic Medicine?
por: Nagpal, Ravinder, et al.
Publicado: (2014)

Genes, emotions and gut microbiota: The next frontier for the gastroenterologist
por: Panduro, Arturo, et al.
Publicado: (2017)

Opicapone Pharmacokinetics and Effects on Catechol-O-Methyltransferase Activity and Levodopa Pharmacokinetics in Patients With Parkinson Disease Receiving Carbidopa/Levodopa
por: LeWitt, Peter, et al.
Publicado: (2023)

Bioinformatics: The Next Frontier of Metabolomics
por: Johnson, Caroline H., et al.
Publicado: (2014)

CPR and ECMO: The Next Frontier
por: Ambinder, Daniel I., et al.
Publicado: (2020)

The next frontier of systems biology: higher-order and interspecies interactions
por: Fischbach, Michael A, et al.
Publicado: (2010)

The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer
por: Pellegrino, Nicole E., et al.
Publicado: (2022)

Cardio-Obstetrics: the Next Frontier in Cardiovascular Disease Prevention
por: Thakkar, Aarti, et al.
Publicado: (2022)

Next frontier in tumor immunotherapy: macrophage-mediated immune evasion
por: Qiu, Yingqi, et al.
Publicado: (2021)

Unraveling protein dynamics to understand the brain – the next molecular frontier
por: Brewer, Kyle D., et al.
Publicado: (2022)

Functional Precision Oncology: The Next Frontier to Improve Glioblastoma Outcome?
por: Panovska, Dena, et al.
Publicado: (2022)

The Next Frontier in Sarcoma: Molecular Pathways and Associated Targeted Therapies
por: Kim, Ted, et al.
Publicado: (2023)

CJC Pediatric and Congenital Heart Disease: The Next Frontier
por: Harris, Kevin C.
Publicado: (2022)

Cone beam navigation bronchoscopy: the next frontier
por: Cheng, George Z., et al.
Publicado: (2020)

Caloric vestibular stimulation for the management of motor and non-motor symptoms in parkinson's disease: Intention-to-treat data
por: Wilkinson, David, et al.
Publicado: (2019)

Cyberbullying in adolescents: the next transition frontier
por: Deely, Derek, et al.
Publicado: (2014)

RNA modification and the epitranscriptome; the next frontier
por: O'Connell, Mary
Publicado: (2015)

Next frontiers in CAR T-cell therapy
por: Brown, Christine E, et al.
Publicado: (2016)

Value: The Next Frontier in Cancer Care
por: Goulart, Bernardo H.L.
Publicado: (2016)

Toward the Next Frontiers of Vibrational Bioimaging
por: Wang, Haomin, et al.
Publicado: (2023)

RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis
por: Morgans, Alicia K., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_205lrqfigev0k2qsmtrkp4lsso